Enrolling 1,000 Patients

May 21, 2020

Enrolling 1,000 Patients

Clinical testing has begun on Gilead’s antiviral drug remdesivir coupled with baricitinib, an anti-inflammatory medicine. The enrollment of more than 1,000 participants is ongoing. In addition to supporting clinical trials, Yourway can also provide all ancillary materials needed during a trial, no matter how large the scale.

Back to Index

Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Clinical Trial Supply West Coast

September 22-23, 2026
Burlingame, CA

Schedule a Meeting

Clinical Trial Supply Forum US

October 6-7, 2026
San Francisco, CA

Schedule a Meeting

Media

Articles

When Every Shipment Represents a Patient

Open chat

Hello! How can I help you?